Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shane K. Ford"'
Autor:
R. Scott Wright, De Lisa Fairweather, Sarah E. Baker, Nigel Paneth, Shane K. Ford, Rickey E. Carter, Katherine A. Senese, Jeffrey P. Henderson, Liise Anne Pirofski, Chad C. Wiggins, Michael J. Joyner, Wayne T. Nicholson, Michael A. Thompson, Bruce Bostrom, Katelyn A. Bruno, Stephen A. Klassen, Jonathon W. Senefeld, Arturo Casadevall, Patrick W. Johnson, William R. Hartman
Publikováno v:
Transfusion
In the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel coronavirus disease 19 (COVID‐19), including among patients with inna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c8c3934bcbe95ef98698c36fcccfa50
http://europepmc.org/articles/PMC8242637
http://europepmc.org/articles/PMC8242637
Autor:
Juan G. Ripoll, Brenna M. Murphy, Kathryn F. Larson, Kylie J. Andersen, Chad C. Wiggins, Stephen A. Klassen, Noud van Helmond, Sarah E. Baker, Michael J. Joyner, Shane K. Ford, Jonathon W. Senefeld, Arturo Casadevall
Publikováno v:
Clinical Microbiology Newsletter
Clinical Microbiology Newsletter, 43, 4, pp. 23-32
Clinical Microbiology Newsletter, 43, 23-32
Clinical Microbiology Newsletter, 43, 4, pp. 23-32
Clinical Microbiology Newsletter, 43, 23-32
Contains fulltext : 232888.pdf (Publisher’s version ) (Closed access) Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being wid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c285f65b154c220b25602d3736927e
Autor:
Shane K. Ford, De Lisa Fairweather, Bruce Bostrom, Rickey E. Carter, Arturo Casadevall, William R. Hartman, Jonathon W. Senefeld, Katelyn A. Bruno, Jeffrey P. Henderson, Michael J. Joyner, Michael A. Thompson, Chad C. Wiggins, Stephen A. Klassen, Sarah E. Baker, Nigel Paneth, Patrick W. Johnson, Wayne T. Nicholson, Liise Anne Pirofski, R. Scott Wright
0AbstractIn the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2 including among patients with innate or acquired immunodeficiency. However, the association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17690e2c9c05d26c572e8d7f3f4c1b9c
https://doi.org/10.1101/2020.11.08.20224790
https://doi.org/10.1101/2020.11.08.20224790
Autor:
Kylie J. Andersen, Stephen A. Klassen, Kathryn F. Larson, Juan G. Ripoll, Jonathon W. Senefeld, Andrew J. Clayburn, John R.A. Shepherd, Andrew S. Tseng, Chad C. Wiggins, Brenna M. Murphy, Shane K. Ford, Christopher P. Johnson, Andrew D. Miller, Sarah E. Baker, R. Scott Wright, Jeffrey L. Winters, James R. Stubbs, Michael J. Joyner, Camille M. van Buskirk
Publikováno v:
Mayo Clinic Proceedings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29aa9a28adef707f4560610c293cbcd7
http://europepmc.org/articles/PMC7505567
http://europepmc.org/articles/PMC7505567